proline has been researched along with Drug Withdrawal Symptoms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cherniakova, IV; Gudasheva, TA; Klodt, PM; Kolik, LG; Konstantinopol'skiĭ, MA; Kudrin, VS | 1 |
| Adeniji, A; Elgadi, M; Huang, F; Joseph, D; Riesenberg, RR; Schobelock, MJ; Vince, BD; Webster, LR | 1 |
| Espiner, EA; Ikram, H; Maslowski, AH; Nicholls, MG | 1 |
| Espiner, EA; Ikram, H; Maslowski, AH; Nicholls, MG; Turner, JG | 1 |
| Creekmore, JS; DeForrest, JM; Ferrone, RA | 1 |
| Espiner, EA; Ikram, H; Maslowski, AH; Nicholls, MG; Penman, T; Scandrett, MS | 1 |
| Costall, B; Domeney, AM; Gerrard, PA; Horovitz, ZP; Kelly, ME; Naylor, RJ; Tomkins, DM | 1 |
| McMahon, T | 1 |
1 trial(s) available for proline and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Effect of steady-state faldaprevir on the pharmacokinetics of steady-state methadone and buprenorphine-naloxone in subjects receiving stable addiction management therapy.
Topics: Administration, Oral; Adult; Aminoisobutyric Acids; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Drug Interactions; Female; Humans; Leucine; Male; Methadone; Middle Aged; Oligopeptides; Proline; Quinolines; Substance Withdrawal Syndrome; Substance-Related Disorders; Thiazoles; Young Adult | 2015 |
7 other study(ies) available for proline and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
[Neurotensin NT (8- 13) dipeptide analog dilept increases the pain threshold and decreases the severity of morphine withdrawal syndrome in rats].
Topics: Animals; Dopamine; Frontal Lobe; Hypothalamus; Male; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Neurotensin; Pain; Pain Threshold; Peptide Fragments; Proline; Rats; Serotonin; Severity of Illness Index; Substance Withdrawal Syndrome; Tyrosine | 2013 |
Absence of rebound deterioration in cardiac function upon withdrawal of captopril for heart failure.
Topics: Captopril; Heart Failure; Hemodynamics; Humans; Proline; Substance Withdrawal Syndrome | 1981 |
Haemodynamic, hormonal, and electrolyte responses to withdrawal of long-term captopril treatment for heart failure.
Topics: Aged; Angiotensin II; Captopril; Cardiac Output; Female; Heart Failure; Heart Rate; Hemodynamics; Hormones; Humans; Male; Middle Aged; Potassium; Proline; Sodium; Substance Withdrawal Syndrome; Time Factors | 1981 |
Hypertension after ending captopril administration: pathogenesis in 2-kidney, 1-clip rat.
Topics: Animals; Body Water; Captopril; Guanethidine; Hemodynamics; Humans; Hypertension; Male; Proline; Rats; Rats, Inbred Strains; Renin; Sodium; Substance Withdrawal Syndrome | 1984 |
Hemodynamic and hormonal responses during captopril therapy for heart failure: acute, chronic and withdrawal studies.
Topics: Aged; Aldosterone; Angiotensin II; Captopril; Dose-Response Relationship, Drug; Female; Heart Failure; Hemodynamics; Humans; Hydrocortisone; Long-Term Care; Male; Middle Aged; Proline; Renin; Substance Withdrawal Syndrome | 1982 |
Effects of captopril and SQ29,852 on anxiety-related behaviours in rodent and marmoset.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anxiety; Behavior, Animal; Callitrichinae; Captopril; Diazepam; Drug Interactions; Female; Male; Mice; Organophosphorus Compounds; Proline; Rats; Species Specificity; Substance Withdrawal Syndrome | 1990 |
Bipolar affective symptoms associated with use of captopril and abrupt withdrawal of pargyline and propranolol.
Topics: Bipolar Disorder; Captopril; Drug Therapy, Combination; Female; Humans; Hypertension; Middle Aged; Nortriptyline; Pargyline; Proline; Propranolol; Substance Withdrawal Syndrome | 1985 |